Robarts Research Institute
The Robarts Research Institute is in London, Ontario, Canada with a staff of more than 600 people. Robarts scientists include physicians and physicists, biologists and biomedical engineers, and the range of diseases they study include heart disease, stroke, diabetes, Alzheimer's disease, and many forms of cancer. It is also well known for its medical imaging research. Robarts was amalgamated with the University of Western Ontario in July 2007.
The institute was founded in 1986, under the guidance of neurologist Dr. Henry Barnett, most famous for his work with Aspirin as a preventive therapy for heart attack and stroke. Dr. Mark J. Poznansky became Scientific Director in 1993 and was awarded the Order of Canada in 2005 for his work. He resigned in March 2007 and formed G2G Consulting Inc. The late Dr. John MacDonald served as Scientific Director from 2008 to 2010. In 2015, Dr. Marlys L. Koschinsky was named the Institute's new Scientific and Executive Director.
Current Ongoing Research
Research interests include:
ALS (Lou Gehrig’s disease), Alzheimer’s disease, Arthritis, Atherosclerosis, Biomedical engineering, Biophysics, Brain chemistry/function, Brain imaging, Cancer, Cardiovascular imaging, Cell biology, Cell signalling, Cellular & micro-imaging, Clinical trials, CT imaging, DNA sequencing, Diabetes, Diagnostic imaging, Epilepsy, Functional MRI, Genetics/genomics, Heart disease, High blood pressure, Image-guided surgery & therapy, Immune responses, Immunotherapeutics, Magnetic Resonance Imaging (MRI), Multiple sclerosis, Musculoskeletal imaging, Organ rejection, Osteoporosis, Parkinson’s disease, Poxvirus, Schizophrenia, Spinal cord injury, Stroke, Technology transfer, Transplantation immunology, Ultrasound imaging, Virology, Xenotransplantation